Brief: Aarti Drugs Approves 250 Million Rupees Investment In Subsidiary
29/01/2025 15:31
Jan 29 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* APPROVES 250 MILLION RUPEES INVESTMENT IN SUBSIDIARY
Source text: ID:nBSE18BbCP
Further company coverage: ADRG.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees